ACT EU - Accelerating Clinical Trials · May 08, 2026

ACT EU Multi-stakeholder Platform: call for nominations to Advisory Group

Original title: Multi-stakeholder platform

Call for nominations to the Multi-stakeholder Platform Advisory Group, open until 30 October 2026, to improve the clinical trials environment.

Medium obligation Framework Clinical Trials & Research EU-wide Clinical trials

Call for nominations for the Multi-stakeholder Platform Advisory Group open until 30 October 2026. The programme has established a Multi-stakeholder platform (MSP), which functions asa vehicle for clinical trials stakeholders and regulators to come together, voice their views and collaborate to improve the clinical trials environment for European patients and citizens. The MSP provides the opportunity for stakeholders to exchange views and enable dialogue with regulators through: 1. the creation of a MSP Advisory Group; 2. multi-stakeholder events; 3. consultations, surveys, and other tools to gather stakeholders' feedback.

Dates and deadlines

Regulatory Deadline

October 30, 2026

Read the official source ↗

Published by ACT EU - Accelerating Clinical Trials. HealthSignal links to the original document; the summary above is extracted from the source text.